Current status of surgery for gastric cancer: A review

Gastric Cancer

Volumn 8, Issue 2, 2005, Pages 64-70

  Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gastric adenocarcinoma; Management

Indexed keywords

DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ANASTOMOSIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ENDOSCOPIC SURGERY; ENDOSCOPY; ESOPHAGUS RESECTION; FAMILIAL CANCER; GASTRECTOMY; GENE MUTATION; HOSPITAL CARE; HOSPITAL COST; HUMAN; LAPAROSCOPY; LENGTH OF STAY; LYMPH NODE DISSECTION; NUTRITIONAL SUPPORT; PATIENT CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; TOTAL STOMACH RESECTION; TREATMENT OUTCOME;

ADENOCARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GASTRECTOMY; LAPAROSCOPY; LYMPH NODE EXCISION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS;

EID: 18544363543     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-005-0319-6     Document Type: Review

References (59)

1. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H. Surgical treatment for gastric cancer: the Japanese approach. Semin Oncol 1996;23:360-8.
2. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-61.
3. Brennan MF, Karpeh MS Jr. Surgery for gastric cancer: the American view. Semin Oncol 1996;23:352-9.
4. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph node dissection for gastric cancer. N Engl J Med 1999;340:908-14.
5. Brennan MF. Lymph node dissection for gastric cancer (editorial). New Engl J Med 1999;340:956-8.
6. Yu CC, Levison DA, Dunn JA, Ward LC, Demonakou M, Allum WH, et al. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer 1995;71:1106-10.
7. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five year follow-up. Lancet 1994;343:1309-12.
8. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-5.
9. Shaw D, Blair V, Martin IG. Chromoendoscopic surveillance in a Maori kindred genotypically predisposed to hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy. Gastrointest Endosc 2003;57:AB158.
10. Chen L, Tian H, Chen J, He ZG, Tao SF, Lokesh G, et al. Surgical management of gastric stump cancer: a report of 37 cases. J Zhejiang Univ Sci 2005;6(1):38-42.
11. Ott K, Fink U, Becker K, Stahl A, Dittler HJ, Busch R, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol. 2003;21(24):4604-10.
12. Downey RJ, Akhurst T, Ilson D, Ginsberg R, Bains MS, Gonen M, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol. 2003;21(3):428-32.
13. Habermann CR, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler C, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 2004;230(2):465-71.
14. Burke EC, Karpeh MS, Cordon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 1997;225:262-7.
15. Inaba T, Okinaga K, Fukushima R, Iinuma H, Ogihara T, Ogawa F, et al. Prospective randomized study of two laparotomy incisions for gastrectomy: midline incision versus transverse incision. Gastric Cancer 2004;7(3):167-71.
16. Brown SR, Goodfellow PJ, Adam IJ, Shorthouse AJ. A randomized controlled trial of transverse skin crease vs vertical midline incision for right hemicolectomy. Tech Coloproctol 2004;8(1):15-8.
17. Grantcharov TP, Rosenberg J. Vertical compared with transverse incisions in abdominal surgery. Eur J Surg 2001;167:260-7.
18. Kearns SR, Connolly EM, McNally S, McNamara DA, Deasy J. Randomized clinical trial of diathermy versus scalpel incision in elective midline laparotomy. Br J Surg 2001;88(1):41-4.
19. Colombo M, Maggioni A, Parma G, Scalambrino S, Milani R. A randomized comparison of continuous versus interrupted mass closure of midline incisions in patients with gynecologic cancer. Obstet Gynecol 1997;89:684-9.
20. Gouzi JL, Huguier M, Fagniez PL, Launois B, Flamant Y, Lacaine F, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study. Ann Surg 1989;209:162-6.
21. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five year survival rates in a multicenter randomized Italian trial. Ann Surg 1999;230:170-8.
22. Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998;123:127-30.
23. Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 2004;199(6):880-6.
24. Shibata C, Shiba K, Gunayama Y, Ishii S, Fukushima K, Mizoi T, et al. Outcomes after pylorus-preserving gastrectomy for early gastric cancer: a prospective multicenter trial. World J Surg 2004;28:857-61.
25. van de Velde CJ, Sasako M. Surgical treatment of gastric cancer: anatomical borders and dissection of lymph nodes. Ann Chir Gynaecol 1998;87:89-98.
26. Martin RCG, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival vs increased morbidity. Ann Surg 2002;236:159-65.
27. Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF. Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 1999;3:24-33.
28. Hori S, Ochiai T, Gunji Y, Hayashi H, Suzuki T. A prospective randomized trial of hand-sutured versus mechanically stapled anastomoses for gastroduodenostomy after distal gastrectomy. Gastric Cancer 2004;7(1):24-30.
29. Osugi H, Fukuhara K, Takada N, Takemura M, Kinoshita H. Reconstructive procedure after distal gastrectomy to prevent remnant gastritis. Hepatogastroenterology 2004;51(58):1215-8.
30. Nomura E, Shinohara H, Mabuchi H, Sang-Woong L, Sonoda T, Tanigawa N. Postoperative evaluation of the jejunal pouch reconstruction following proximal and distal gastrectomy for cancer. Hepatogastroenterology 2004;51(59):1561-6.
31. Shiraishi N, Hirose R, Morimoto A, Kawano K, Adachi Y, Kitano S. Gastric tube reconstruction prevented esophageal reflux after proximal gastrectomy. Gastric Cancer 1998;1:78-9.
32. Tomita R, Tanjoh K, Fujisaki S. Total gastrectomy reconstructed by interposition of a jejunal J pouch with preservation of hepatic vagus branch and lower esophageal sphincter for T2 gastric cancer without lymph node metastasis. Hepatogastroenterology 2004;51(58):1233-40.
33. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer. Gastric Cancer 1998;1:152-9.
34. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC Randomized Surgical Trial, Surgical Cooperative Group. Br J Cancer 1999;79:1522-30.
35. Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 2004;30(3):303-8.
36. Edwards P, Blackshaw GR, Lewis WG, Barry JD, Allison MC, Jones DR. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer 2004;90(10):1888-92.
37. Siewert JR, Kestlmeier R, Busch R, Bottcher K, Roder JK, Muller J. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-7.
38. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg 1997;84:567-71.
39. Sasako M. Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003;21:274s-5s.
40. McCulloch P, Nita M, Kazi H, Gama-Rodrigues J. Extended versus limited lymph node dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2004;4:CD001964.
41. Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501. J Clin Oncol 2004;22(14):2767-73.
42. Katai H, Sasako M, Sano T, Fukagawa T. Gastric cancer surgery in the elderly without operative mortality. Surg Oncol 2004;13(4):235-8.
43. Coniglio A, Tiberio GA, Busti M, Gaverini G, Baiocchi L, Piardi T, et al. Surgical treatment for gastric carcinoma in the elderly. J Surg Oncol 2004;88(4):201-5.
44. Doglietto GB, Papa V, Tortorelli AP, Bosssola M, Covino M, Pacelli F. Nasojejunal tube placement after total gastrectomy: a multicenter prospective randomized trial. Arch Surg 2004;139:1309-13.
45. Conlon KC, Labow D, Leung D, Smith A, Jarnagin W, Coit DG, et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg 2001;234:487-94.
46. Heslin MJ, Latkany L, Leung D, Brooks AD, Hochwald SN, Pisters PWT, et al. A prospective randomized trial of early enteral feeding after resection of upper GI malignancy. Ann Surg 1997;226:567-80.
47. Brennan MF, Pisters PWT, Posner MC, Queseda O, Shike M. A prospective randomized trial of total parenteral nutrition following major pancreatic resection for malignancy. Ann Surg 1994;22:436-44.
48. Roviello F, Fotia G, Marrelli D, De Stefano A, Macchiarelli R, Pinto E. Iron deficiency anemia after subtotal gastrectomy for gastric cancer. Hepatogastroenterology 2004;51(59):1510-4.
49. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004;240:808-16.
50. Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg 2005;92:235-9.
51. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy and lung lobectomy in patients with cancer. Surgery 2002;131:6-15.
52. Birkmeyer NJ, Goodney PP, Stukel Ta, Hillner BE, Birkmeyer JD. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 2005;103:435-41.
53. Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh M, Brennan MF. Is gastric cancer different between Japan and the United States? A comparison of patient survival among three institutions. Cancer 2000;89:2237-46.
54. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, et al. Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology 2004;51(58):1225-8.
55. Desai AM, Pareek M, Nightingale PG, Fielding JW. Improving outcomes in gastric cancer over 20 years. Gastric Cancer 2004;7:196-201.
56. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: is location more important than number? An analysis of 1038 patients. Ann Surgery 2000;232:362-71.
57. Peeters KCMJ, Kattan MW, Hartgrink HH, Kranenbarg EK, Karpeh MS, Brennan MF, et al. Validation of a nomogram for predicting disease-specific survival following a R0 resection for gastric cancer. Cancer 2005;103:702-7.
58. Fondevila C, Metges JP, Fuster J, Grau JJ, Palacin A, Castells A, et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 2004;90(1):206-15.
59. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg 2003;237:828-35.